OpenAI's latest tool performs tasks autonomously, which it says is the company's latest step toward AGI.

The Dow Jones Industrial Average (DJIA) continued its steady drift into the high end on Thursday, gaining 0.8% and adding around 350 points to the tally as investors broadly tilt into a risk on stance ...

Boston Scientific Corp (BSX) stock saw a decline, ending the day at $100.31 which represents a decrease of $-0.60 or -0.59% from the prior close of $100.91. The stock opened at $100.91 and touched a ...

Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships in 2025. Click for this ARQT update.

Since it was issued, trading volume of the $Trump coin has approached that of some of the largest cryptos out there, including solana and ethereum.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 15.45% ...

These three smaller-cap companies with lower-priced stocks could offer patient investors enormous returns for the rest of 2025 and beyond.

Is BioMarin stock a bargain or a falling knife? Learn about key issues affecting its investment prospects and potential for recovery.

As for his fresh call, the strategist now talks about a "monster vibe shift'" that has spread from those macro trades to equities. He notes downside risk hedging via bearish put options has given way ...

It has been 26 years since Nvidia has gone public. The stock has crashed in four of these years. So it's certainly possible ...

On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are ...

Investors hope these developments can fuel a rebound for a stock that peaked at nearly $60 per share a few years ago, but has ...